THE ROLE OF ANTIBODIES TO ELASTIN IN VARIOUS CLINICAL VARIANTS OF THE COURSE OF SYSTEMIC SCLERODERMA

被引：0
|
作者：
Korenskaya, E. G. [1 ]
Paramonova, O. V. [1 ]
Shilova, L. N. [1 ]
Korolik, O. D. [1 ]
机构：
[1] Volgograd State Med Univ, Volgograd, Russia
来源：
OSTEOPOROSIS INTERNATIONAL | 2021年 / 32卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P228
引用
收藏
页码：S165 / S166
页数：2
相关论文
共 50 条
  • [21] SERUM ANTINUCLEAR ANTIBODIES IN PROGRESSIVE SYSTEMIC SCLEROSIS (SCLERODERMA)
    ROTHFIELD, NF
    RODNAN, GP
    ARTHRITIS AND RHEUMATISM, 1968, 11 (05): : 607 - +
  • [22] The role of the scleroderma society (UK) in improving recruitment to clinical trials in systemic sclerosis
    Fligelstone, K.
    Dziadzio, M.
    Smith, R.
    Stratton, R.
    Denton, C.
    Black, C.
    RHEUMATOLOGY, 2006, 45 : I182 - I182
  • [23] Keloid morphea and nodular scleroderma: Two distinct clinical variants of scleroderma?
    Rencic, A
    Brinster, NK
    Nousari, CH
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2003, 7 (01) : 20 - 24
  • [24] Role of antiidiotypic antibodies on the clinical course of idiopathic thrombocytopenic purpura
    Mehta, YS
    Ghosh, K
    Badakere, SS
    Pathare, AV
    Mohanty, D
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2003, 142 (02): : 113 - 120
  • [25] CLINICAL COMPARISON OF 2 VARIANTS OF PROGRESSIVE SYSTEMIC-SCLEROSIS (PSS) - DIFFUSE SCLERODERMA AND CREST SYNDROME
    STEEN, VD
    MEDSGER, TA
    ZIEGLER, G
    RODNAN, GP
    CLINICAL RESEARCH, 1980, 28 (01): : A150 - A150
  • [26] MARKER ANTIBODIES IN SCLERODERMA AND POLYMYOSITIS - CLINICAL ASSOCIATIONS
    DEROOIJ, DJ
    VANDEPUTTE, LBA
    HABETS, WJ
    VANVENROOIJ, WJ
    CLINICAL RHEUMATOLOGY, 1989, 8 (02) : 231 - 237
  • [27] ANTIPHOSPHOLIPID ANTIBODIES IN SCLERODERMA: PREVALENCE AND CLINICAL SIGNIFICANCE
    Bertolaccini, M. L.
    Sanna, G.
    Mameli, A.
    Khamashta, M. A.
    Mathieu, A.
    Hughes, G. R. V.
    RHEUMATOLOGY, 2002, 41 : 103 - 103
  • [28] Autoreactive IgA antibodies are high prevalent and associated with clinical manifestations in systemic lupus erythematosus, systemic scleroderma and idiopathic inflammatory myositis
    Li, Quanzhen
    Wei, Junxia
    Luo, Hui
    Zhu, Honglin
    Zhu, Chengsong
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
  • [29] A role for ITPA variants in the clinical course of pulmonary Langerhans' cell histiocytosis?
    Bakker, J. A.
    Bierau, J.
    Drent, M.
    EUROPEAN RESPIRATORY JOURNAL, 2010, 36 (03) : 684 - 686
  • [30] CLINICAL ASPECTS OF SYSTEMIC-SCLEROSIS (SCLERODERMA)
    SILVER, RM
    ANNALS OF THE RHEUMATIC DISEASES, 1991, 50 : 854 - 861
12345